Compare Citius Pharmaceuticals Inc (CTXR) vs KLA Corp. (KLAC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citius Pharmaceuticals Inc vs KLA Corp. — how do they compare? Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M), while KLA Corp. trades at $208.48 (market cap $261.92B). The key difference: KLA Corp. is far larger — about 13089.5× Citius Pharmaceuticals Inc's market cap, and KLA Corp. pays a 0.46% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| CTXR | KLAC | |
|---|---|---|
Market Cap | $20.01M | $261.92B |
Sector | Health | Technology |
52-Week High | $1.82 | $301.71 |
52-Week Low | $0.48 | $84.39 |
Enterprise Value | $16.23M | $263.17B |
Dividend Yield | — | 0.46% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →About KLA Corp.
KLA designs and manufactures yield-management and process-monitoring diagnostic and control systems for the semiconductor manufacturing industry. The systems are used to analyze the manufacturing process at various steps in a semiconductor's development. The firm's laser-scanning products are used for wafer qualification, process monitoring, and equipment monitoring. KLA also provides inspection tools and systems for optical metrology and e-beam metrology.
Read more on KLAC →
